Comparative cardiovascular effects of GLP‐1 agonists using real‐world data

AIMS: There is limited research using real‐world data to evaluate protective cardiovascular effects of glucagon‐like peptide‐1 (GLP‐1) agonists among adults with type 2 diabetes (T2D) early in treatment. MATERIALS AND METHODS: We conducted a retrospective, active comparator cohort study using 2011–2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallia, Amisha, O’Brien, Matthew, Hakimian, Stephanie, Kang, Raymond, Cooper, Andrew, Lancki, Nicola, Stephen, John J., Aikman, Cassandra, Liss, David, Parker, Emily, Ackermann, Ronald T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164426/
https://www.ncbi.nlm.nih.gov/pubmed/36825925
http://dx.doi.org/10.1002/edm2.339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164426/
https://www.ncbi.nlm.nih.gov/pubmed/36825925
http://dx.doi.org/10.1002/edm2.339

Ejemplares similares